In Vitro Diagnostics Product Development
As biotech and In Vitro Diagnostics (IVD) companies mature, the need for professionals with a broad understanding of the skills required to be effective in a biological product development environment will increase. In this course, learn the requirements for moving an IVD product from concept to regulatory approval and market launch. Topics include planning for success by setting product requirements & specifications to meet customer needs, critical path management, resource planning, principles of assay development, instrumentation, role and composition of the product development team, risk analysis, and IVD clinical and regulatory issues including compliance and complaint handling. Specific product development cases will be discussed.
Who Should Attend
This course is geared towards managers, entrepreneurs, investors and scientists seeking an overview of the regulatory, clinical, scientific and business aspects of In Vitro Diagnostic product development.
Due to circumstances stemming from COVID-19, this course will be offered in a live online format. This course will use Zoom conference call technology instead of traditional classroom meetings. Please see below for course dates and times.
- Introduction to the IVD World
- Package Insert – Begin with end in mind
- Product Development Process
- Resource Planning
- Design Control
- Customer Input, PRD
- Product Risk Analysis
- Case Study 1- DNA Sequencing
- Group Assignment and Breakout
- Business Case (NPV, IRR, Standard Costs)
- Case Study 2 – COVID
- Principles of Assay Development
- Companion Diagnostics
- Group Assignment and Breakout - Companion Diagnostics
- Instrumentation/ Software in IVD
- Design and Conduct of Preclinical and Clinical Trials
- Regulatory Overview
- Exam Review
- Larry Mimms, Ph.D., Chief Executive Officer, ProciseDX
- Valerie Day, MBA, Vice President, Product Development, ProciseDX
- Damon Getman, Ph.D., Chief Scientist, Diagnostics Scientific Affairs, Hologic
- Al Maderazo, VP, Quality Assurance and Regulatory Affairs, GenMark Diagnostics
Note: Due to circumstances stemming from COVID-19, this course will be offered in a live online format. This course will use Zoom conference call technology instead of traditional classroom meetings.
Course Number: BIOL-40244
Credit: 2.00 unit(s)
+ Expand All
4/18/2023 - 5/4/2023
Synchronous web-based class meetings that are scheduled to meet online at published times (time/date).
Mimms, Larry, Chief Scientific Officer, Prometheus Laboratories
Larry Mimms, Ph.D. is chief scientific officer at Prometheus Labs. Previously he served as head of product development for Human Longevity. From 2009 to 2014, Dr. Mimms served as vice president R&D Quidel Corp., a world leader in development of point of care and rapid tests. Prior to his work at Quidel, Dr. Mimms founded VDx LLC in 2008 to develop rapid, point of care HIV diagnostic tests. From 1994 to 2007 Dr. Mimms held a number of executive positions at Gen-Probe including executive vice president, research and development from 2005-2007 and vice president of development, and vice president of strategic planning and business development. Dr. Mimms initiated and headed up the Gen-Probe blood bank program from 1996 to 2002. In 1996, he and his ...Read More
No refunds after: 4/19/2023.
|4/18/2023||Tue||4:00 p.m.||7:00 p.m.|
|4/20/2023||Thu||4:00 p.m.||7:00 p.m.|
|4/25/2023||Tue||4:00 p.m.||7:00 p.m.|
|4/27/2023||Thu||4:00 p.m.||7:00 p.m.|
|5/2/2023||Tue||4:00 p.m.||7:00 p.m.|
|5/4/2023||Thu||4:00 p.m.||7:00 p.m.|
There are no sections of this course currently scheduled. Please contact the Science & Technology department at 858-534-3229 or firstname.lastname@example.org for information about when this course will be offered again.